Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2012-06-20

Clinical Trial Update: Effect of Topical Imiquimod on Lentigo Maligna [Phase 4]

View source ↗

Summary

Phase 4 trial evaluating topical imiquimod for Lentigo Maligna has completed. The document reports the study status as COMPLETED.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Aldara (imiquimod)

Snippet

Sponsor: Jerry Marsden | Conditions: Lentigo Maligna | Phase 4 | Status: COMPLETED